PlainHospital

BECTON, DICKINSON & CO., (BD)

Manufacturer adverse-event records for BECTON, DICKINSON & CO., come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2010–2026 · mid-book · quiet Death-code · injury-light

Death-code intensity

BECTON, DICKINSON & CO., is quieter on Death-coded events

Death-coded event_type rows are 0 of 12,552 (0.00% · quiet tercile among 434 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for BECTON, DICKINSON & CO., (BD)

The standout signal for BECTON, DICKINSON & CO., (BD) is Death-code intensity: 0.00% of 12,552 reports (quiet tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for BECTON, DICKINSON & CO.,. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 11,775 (93.8% of event_type total). Peak single-year volume reaches 2,168 reports across 14 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

12,552
Total Reports
0
Event-type Death
776
Injury Reports
20
Device Types

Event Types

Malfunction 11,775 (93.8%)
Injury 776 (6.2%)
1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Other 6,134 (48.8%)
5,988 (47.6%)
Required Intervention 413 (3.3%)
R 15 (0.1%)
O 13 (0.1%)
Death 3 (0.0%)
Hospitalization 2 (0.0%)
Life Threatening 1 (0.0%)

Devices (20)

Device Reports
Tubes, Vials, Systems, Serum Separators, Blood Collection 9,436
Needle, Hypodermic, Single Lumen 2,418
Set, Administration, Intravascular 556
Container, Specimen, Sterile 93
Syringe, Piston 17
Monitor, Microbial Growth 7
Culture Media, Non-Propagating Transport 5
Discs, Strips And Reagents, Microorganism Differentiation 4
Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days 3
Lymphocyte Separation Medium 2
Blood Specimen Collection Convenience Kit (Excludes Hiv) 1
Coronavirus Antigen Detection Test System. 1
Culture Media, Non-Selective And Differential 1
Culture Media, Non-Selective And Non-Differential 1
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System 1
Saline, Vascular Access Flush 1
Set, I.V. Fluid Transfer 1
Syringe, Antistick 1
System, X-Ray, Tomography, Computed 1
Tubes, Vacuum Sample, With Anticoagulant 1

Yearly Trend

10
2010: 1
13
2013: 1
15
2015: 7
16
2016: 59
17
2017: 1,188
18
2018: 2,070
19
2019: 2,168
20
2020: 1,027
21
2021: 903
22
2022: 792
23
2023: 953
24
2024: 1,377
25
2025: 2,003
26
2026: 3

Read our methodology - how this data is sourced, computed, and verified.